Forian (FORA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Voting matters and shareholder proposals
Election of Stanley S. Trotman, Jr. and Kristiina Vuori, M.D., Ph.D. as Class I directors to serve until the 2028 annual meeting or until successors are elected and qualified.
Proposal to amend the 2020 Equity Incentive Plan, increasing authorized shares for issuance by 4,000,000.
Ratification of CBIZ CPAS P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2025.
Other business may be addressed as appropriate at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all director nominees and proposals.
Directors up for election are nominated for three-year terms, expiring at the 2028 annual meeting.
Executive compensation and say-on-pay
Proposal to amend the equity incentive plan would increase the pool of shares available for executive and employee compensation.
Latest events from Forian
- Q2 revenue fell 2% to $4.8M, net loss widened, and 2024 guidance was lowered.FORA
Q2 20241 Feb 2026 - Q3 2024 revenue fell 12% to $4.7M; Kyber acquisition and sales momentum set up future growth.FORA
Q3 202414 Jan 2026 - Re-domiciliation from Delaware to Maryland approved by majority stockholder vote.FORA
EGM 20268 Jan 2026 - Stockholders to vote on redomiciling to Maryland, enabling a take-private offer and strategic flexibility.FORA
Proxy Filing15 Dec 2025 - Redomiciliation to Maryland is proposed to enable a take-private offer, with majority support assured.FORA
Proxy Filing4 Dec 2025 - Annual meeting to vote on director elections, equity plan expansion, and auditor ratification.FORA
Proxy Filing1 Dec 2025 - Q1 2025 revenue up 45% to $7.1M, with narrowed net loss and strong 2025 growth outlook.FORA
Q1 202526 Nov 2025 - Q2 2025 revenue up 57% to $7.5M, with positive net income and strong outlook for 2025.FORA
Q2 202523 Nov 2025 - Q3 2025 revenue surged 66% to $7.8M, with improved margins and strong year-end outlook.FORA
Q3 202517 Nov 2025